skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
AND
OR
NOT
This feature requires javascript
Rosuvastatin kao dio strategije primarne prevencije kardiovaskularnih bolesti
Cardiologia Croatica, 2013-03, Vol.8 (3-4), p.142
ISSN: 1848-543X ;EISSN: 1848-5448
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Rosuvastatin kao dio strategije primarne prevencije kardiovaskularnih bolesti
Author:
Meško, Jasna
;
Brus, Sanja
;
Barbič-Žagar, Breda
Subjects:
cardiovascular disease
;
kardiovaskularna bolest
;
primarna prevencija
;
primary prevention
;
rosuvastatin
Is Part Of:
Cardiologia Croatica, 2013-03, Vol.8 (3-4), p.142
Description:
Patients with established cardiovascular disease (CVD) are the ones that are most commonly considered for therapeutic intervention in order to prevent progression of the disease. In contrast, patients without manifested CVD and at increased risk are often left untreated, even though they would have the greatest benefits from early risk reduction in terms of CVD prevention. According to the recently published European CVD prevention guidelines, the reduction of LDL cholesterol must be of prime concern in the prevention of CVD. With potent statins, such as rosuvastatin, we can achieve meaningful reductions of LDL cholesterol levels and, consequently, reduce an individual’s total CVD risk. On the basis of a large clinical study with rosuvastatin, prevention of major cardiovas- cular events in patients who are estimated to have a high risk was added to statin labels. A post hoc analysis of this clinical study which included only patients considered to be at high risk, showed that patients with a 10-year Framingham risk score of >20% or an estimated SCORE risk of >5% had statistically significant reductions, 50% and 43%, respectively, in the risk of MI, stroke, or cardiovascular death when treated with rosuvastatin compared with patients treated with placebo. Rosuvastatin also has established benefits in other high-risk patients, such as patients with diabetes and hypertension. Long-term compliance with statin therapy is critical for its efficacy in patients at high risk. With long-term statin treatment we can achieve greater reductions of the CVD risk and an even more pro- nounced regression of atherosclerotic plaques.
Publisher:
Hrvatsko kardiološko društvo
Language:
Croatian;English
Identifier:
ISSN: 1848-543X
EISSN: 1848-5448
Source:
GFMER Free Medical Journals
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript